CH661867A5 - Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin. - Google Patents

Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin. Download PDF

Info

Publication number
CH661867A5
CH661867A5 CH2838/84A CH283884A CH661867A5 CH 661867 A5 CH661867 A5 CH 661867A5 CH 2838/84 A CH2838/84 A CH 2838/84A CH 283884 A CH283884 A CH 283884A CH 661867 A5 CH661867 A5 CH 661867A5
Authority
CH
Switzerland
Prior art keywords
preparation
human
diltiazem
pharmaceutically acceptable
medicine
Prior art date
Application number
CH2838/84A
Other languages
German (de)
English (en)
Inventor
Kohki Takashima
Shuji Nitta
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of CH661867A5 publication Critical patent/CH661867A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CH2838/84A 1983-06-10 1984-06-12 Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin. CH661867A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58104691A JPS59231018A (ja) 1983-06-10 1983-06-10 抗脂血剤

Publications (1)

Publication Number Publication Date
CH661867A5 true CH661867A5 (de) 1987-08-31

Family

ID=14387491

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2838/84A CH661867A5 (de) 1983-06-10 1984-06-12 Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin.

Country Status (12)

Country Link
JP (1) JPS59231018A (cs)
BE (1) BE899867A (cs)
CH (1) CH661867A5 (cs)
DE (1) DE3419425A1 (cs)
DK (1) DK164021C (cs)
FR (1) FR2547730B1 (cs)
GB (1) GB2141027B (cs)
HK (1) HK45489A (cs)
IT (1) IT1196710B (cs)
NL (1) NL8401793A (cs)
SE (1) SE465352B (cs)
SG (1) SG21089G (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389446B (de) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels
AT390880B (de) * 1986-05-23 1990-07-10 Tanabe Seiyaku Co Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS58208222A (ja) * 1982-05-28 1983-12-03 Japan Found Cancer 抗腫瘍剤効果増強剤
JPS5970611A (ja) * 1982-10-15 1984-04-21 Tanabe Seiyaku Co Ltd 医薬組成物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390880B (de) * 1986-05-23 1990-07-10 Tanabe Seiyaku Co Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung
AT389446B (de) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels

Also Published As

Publication number Publication date
NL8401793A (nl) 1985-01-02
JPS59231018A (ja) 1984-12-25
DE3419425C2 (cs) 1989-06-08
JPS6317810B2 (cs) 1988-04-15
HK45489A (en) 1989-06-16
GB2141027B (en) 1986-10-22
DE3419425A1 (de) 1984-12-13
GB2141027A (en) 1984-12-12
FR2547730B1 (fr) 1987-11-13
SE8403042L (sv) 1984-12-11
DK164021C (da) 1992-09-28
IT8467596A0 (it) 1984-06-08
SE465352B (sv) 1991-09-02
SE8403042D0 (sv) 1984-06-06
DK284084A (da) 1984-12-11
DK164021B (da) 1992-05-04
GB8414498D0 (en) 1984-07-11
IT1196710B (it) 1988-11-25
IT8467596A1 (it) 1985-12-08
BE899867A (fr) 1984-10-01
FR2547730A1 (fr) 1984-12-28
DK284084D0 (da) 1984-06-08
SG21089G (en) 1990-01-26

Similar Documents

Publication Publication Date Title
EP0188810B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Verhinderung oder Behandlung posttraumatischer Nervenschäden nach unfallbedingten Rückenmarks- und/oder Gehirntraumen
EP0185210B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE3319347C2 (cs)
EP0607776A2 (de) Verwendung von Leflunomid zur Hemmung von Tumornekrosefaktor alpha
DE69614419T2 (de) Transdermale Formulierung eines Mittels muscarinischer Wirkung
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
CH661867A5 (de) Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin.
DE2726392A1 (de) Mittel zur bekaempfung der venoesen thrombose
EP0607777A2 (de) Verwendung von Leflunomid zur Herstellung von Interleukin 8
DE4024885A1 (de) Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE69308762T2 (de) Behandlung des Muskulschwunds
DE3212909C2 (cs)
DE3141970C2 (cs)
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
EP0005732B1 (de) Verwendung von 2-Amino-oxazolo- oder 2-Amino-thiazolo-[5,4-d]azepinen sowie deren Säureadditionssalzen zur Herstellung eines Arzneimittels für die Verwendung bei der Bekämpfung von Angina Pectoris
DE2209526C3 (de) Coronartherapeutlkum in Form von Gelatine-BeiBkapseln
DE3406837C2 (cs)
DE3781456T2 (de) Pharmazeutische zusammensetzung, die eine 8-chlor-benzothiazepin-verbindung enthaelt und ihre verwendung.
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE2728589A1 (de) Verwendung von 2-(2,2-disubstituierten)-aethylimidazolinen bei der bekaempfung von diabetes
DE3714322C2 (de) Prophylaktisches und therapeutisches Mittel für hepatische Krankheiten
EP0604830B1 (de) Verwendung mindestens eines Paf-Antagonisten zur Herstellung eines Arzneimittels zur Behandlung oder Vorbeugung des Hyperinsulinismus
WO1993024130A1 (de) (-)-metrifonat enthaltendes arzneimittel
DE69630561T2 (de) Verwendung von 4-Amino-6-hydroxypyrazolo[3,4-d]pyrimidin zur Herstellung eines blutdrucksenkenden Mittels
DE2636328A1 (de) Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased